InvestorsHub Logo
Followers 14
Posts 818
Boards Moderated 1
Alias Born 11/13/2019

Re: None

Wednesday, 08/09/2023 8:05:18 AM

Wednesday, August 09, 2023 8:05:18 AM

Post# of 437
$PGEN - 👆 Up 12% Pre-Market/Current Price $1.33
👉Announces FDA Confirmation that the Ongoing Phase 1/2 Study of PRGN-2012 AdenoVerse Immunotherapy Will Serve as the Pivotal Study to Support Accelerated Approval
👉And provides Financial Results and updates

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.